A high throughput enzyme-linked immunosorbent assay for inhibitors of the interaction between retinoblastoma protein and the Leu-X-Cys-X-Glu motif

Journal of Biomolecular Screening

Volumn 2, Issue 4, 1997, Pages 207-211

  Ellsmore, Victoria Alice ^a   Teoh, Ai Peng ^b   Ganesan, Arasu ^b  

^a University of Bath   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18844444558     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705719700200405     Document Type: Article

References (20)

1. Weinberg, R.A. (1996). How cancer arises. Sci. Am. 275:62.
2. Oliff, A., Gibbs, J.B., McCormick, F. (1996). New molecular targets for cancer therapy. Sci. Am. 275:144.
3. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81:323.
4. Paggi, M.G., Baldi, A., Bonetto, F., Giordano, A. (1996). Retinoblastoma protein family in cell cycle and cancer: A review. J. Cell. Biochem. 62:418.
5. Sánchez, I., Dynlacht, B.D. (1996). Transcriptional control of the cell cycle. Curr. Op. Cell. Biol. 8:318.
6. Jansen-Dürr, P. (1996). How viral oncogenes make the cell cycle. Trends Genet. 12:270.
7. Taya, Y. (1997). RB kinases and RB-binding proteins: New points of view. Trends Biochem Sci. 22:14.
8. Pfister, H. (1996). The role of human papillomavirus in anogenital cancer. Obstet. Gynecol. Clin. North Am. 23:579.
9. Hall, M., Peters, G. (1996). Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:67.
10. Smith, D.B., Corcoran, L.M. (1991). Expression and purification of glutathione-S-transferase fusion proteins. In Current Protocols in Molecular Biology. F.A. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl (eds.), pp. 16.7.1-16.7.8. Greene Publishing and Wiley-Interscience, New York.
11. Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248.
12. Jones, R.E., Wegrzyn, R.J., Patrick, D.R., Balishin, N.L., Vuocolo, G.A., Riemen, M.W., Defeo-Jones, D., Garsky, V.M., Heimbrook, D.C., Oliff, A. (1990). Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J. Biol. Chem. 265:12782.
13. Jones, R.E., Heimbrook, D.C., Huber, H.E., Wegrzyn, R.J., Rotberg, N.S., Stauffer, K.J., Lumma, P.K., Oliff, A. (1992). Specific N-methylations of HPV-16 peptides alter binding to the retinoblastoma suppressor protein. J. Biol. Chem. 267:908.
14. Huber, H.E., Koblan, K.S., Heimbrook, D.C. (1994). Protein-protein interactions as therapeutic targets for cancer. Curr. Med. Chem. 1:13.
15. Patrick, D., Oliff, A., Heimbrook, D.C. (1994). Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J. Biol. Chem. 269:6842.
16. Tam, J.P. (1988). Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85:5409.
17. Tam, J.P. (1996). Recent advances in multiple antigen peptides. J. Immunol. Meth. 196:17.
18. Palmieri, G., Cassani, G., Fassina, G. (1995). Peptide immobilization on calcium alginate beads-applications to antibody purification and assay. J. Chromatog. B 664:127.
19. Hayakawa, Y., Sohda, K.-Y., Shin-ya, K., Hidaka, T., Seto, H. (1995). Anguinomycins C and D, new antitumor antibiotics with selective cytotoxicity against transformed cells. J. Antibiot. 48:954.
20. Hayakawa, Y., Sohda, K.-Y., Seto, H. (1995). Selective cytotoxicity of mycophenolic acid against transformed cells. J. Antibiot. 48:1182.